Much less spend the time to "keeping the share price down" of a .22 cent stock to a company that is worth nothing? There are no "Hedgies" as Hebmasterbator suggests.
The down side is .22 cents, not really worth the effort as the stock will drift to zero on it's own.
There is no upside as the market, clinical trials as well as technology has left HEB's 50 year old drugs behind as they are as valuable as aspirin.
Any shareholder should appreciate the 10k that is soon to come out showing a nice upper 6 to 7 figure bonus for CEO Carter that he took on top of the 1 million plus he siphons off the company.
Meanwhile, you as a shareholder has only watched your HEB holdings decrease in value along with a years of pumping articles from HEB with no, ZERO NONE advancements in ANY clinical trials.
So as Carter would say, "Thank you bagholders for another year of keeping me in the 1%".
The only Animal Data HEB is doing is what Carter's dog likes and doesn't like.
IF ANYONE thinks HEB is doing animal studies or can MFG ANYTHING, please drive by the MFG plant HEB owns. It's vacant.
"When will The Theives leave?"
Do you mean the CEO Carter? I don't know but I'm guessing there will be a 10k shortly announcing a nice end of year bonus for Carter and crew. Then maybe a reverse split and a new ATM offering to refill the HEB coffers so the cycle can repeat.
No "hedgies" want this company.
If they want shares as you suggest, they can just call Carter and he will sell them as many as they want.
Any successful hedge fund could buy this company outright. 35 million is NOTHING to a good hedge fund.
"Blackrock is a hedge fund company, their publicized positions are completely reversed of their strategy .. "
Like how exactly? They currently have 138 million dollars in CLDX stock. Not sure what a "reversed strategy" would be with that kind of holding.